Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Pridopidine for the Treatment of ALS–Improvements in the Subgroup of Definite, Probable, and Early (<18mo from Onset) Subjects in the Phase 2 Healey ALS Platform Trial

              Author:Geva, Michal   Shefner, Jeremy   Oskarsson, Bjorn   Lichtenstein, Rachel G.   Meltzer, May   Cohen, Yael   Hand, Randal   Chen, Kelly   Leitner, Melanie   Paganoni, Sabrina   Cudkowicz, Merit   Hayden, Michael   

              Session Name:S5: Updates on Amyotrophic Lateral Sclerosis  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S5.010  

              Author Institution:Prilenia Therapeutics, Herzlyia, Israel  Barrow Neurological Institute, Phoenix, AZ  Mayo Clinic, Jacksonville, FL  Prilenia Therapeutics, Kibbutz Yakum, Israel  Accelerating NeuroVentures, LLC, Needham, MA  Massachusetts General Hospital, Boston, MA  Prilenia Therapeutics and University of British Columbia, Herzliya, Israel  

              A Statistical Model to Facilitate Differentiation of Chronic Inflammatory Demyelinating Polyneuropathy Versus Mimics

              Author:Swart, Grace   Skolka, Michael   Shelly, Shahar   Lewis, Richard   Allen, Jeffrey   Spies, Judith   Dubey, Divyanshu   Laughlin, Ruple   Thakolwiboon, Smathorn   Santilli, Ashley   Rashed, Hebatallah   Mirman, Igal   Swart, Alexander   Niu, Zhiyv   Berini, Sarah   Shouman, Kamal   Pinto,   

              Session Name:S16: Updates on Nerve and Muscle Disorders  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S16.010  

              Author Institution:University of Sydney, Darlinghurst, Australia  Mayo Clinic, Jacksonville, FL  Rambam Medical Center, Haifa, Israel  Cedars-Sinai Medical Center, Los Angeles, CA  UMN, Minneapolis, MN  Royal Prince Alfred Hospital, Camperdown, Australia  Mayo Clinic, Rochester, MN  Mayo Clinic Rochester, Rochester, MN  Mayo Clinic Health System, La Crosse, WI  

              Expanding the Clinical Phenotypes of Corticobasal Degeneration

              Author:Wetmore, Emma   Uruk, Gokhan   Pham, Nha Trang Thu   Boeve, Bradley   Peterson, Ronald   Dickson, Dennis   Whitwell, Jennifer   Josephs, Keith   

              Session Name:S21: Movement Disorders: Clinical Characteristics and Epidemiology of Movement Disorders  

              Topic:Movement Disorders  

              Program Number:S21.005  

              Author Institution:Mayo Clinic, Rochester, MN  Mayo Clinic, Jacksonville, FL  

              Efficacy and Safety of Anticoagulant and Antiplatelet Therapies in the Medical Management of Carotid Free-Floating Thrombus: a Systematic Review

              Author:Camerotte, Raphael   Vilardo, Marina   Ribeiro, Filipe Virgilio   Bocanegra-Becerra, Jhon E.   Gonçalves, Ocilio Ribeiro   Montecino, Dominique   Souza, Bruna Leles Vieira de   Paleare, Luis   Dominici, Saul   Corvelo, Arthur   Fukunaga, Christian   Mitre, Lucas Pari   Ferreira,   

              Session Name:S30: Stroke Risk Factors, Outcomes, and Prevention  

              Topic:Cerebrovascular Disease and Interventional Neurology  

              Program Number:S30.009  

              Author Institution:Federal University of Rio de Janeiro, Rio de Janeiro, Brazil  Catholic University of Brasilia, Brasilia, Brazil  Mayo Clinic, Jacksonville, FL  Federal University of Maranhão, São Luís, Brazil  University of Grande Rio, Niterói, Brazil  FMABC University Center, São Paulo, Brazil  Lenox Hill Hospital, White Plains, NY  

              Effectiveness and Outcome Predictors of Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease

              Author:Thakolwiboon, Smathorn   Redenbaugh, Vyanka   Chen, Bo   Hewitt, Sage   Shah, Shailee   Lotan, Itay   Levy, Michael   Forcadela, Mirasol   Huda, Saif   Pique, Julie   Marignier, Romain   Boutère, Clémence   Audoin, Bertrand   Poullin, Pascale   Champsas, Dimitrios   Choi, David   Danesh,   

              Session Name:S38: NMOSD, MOGAD, Demyelinating, and Other  

              Topic:Autoimmune Neurology  

              Program Number:S38.004  

              Author Institution:Mayo Clinic Health System, La Crosse, WI  Mayo Clinic, Rochester, MN  John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom  VUMC, Nashville, TN  Vanderbilt Multiple Sclerosis Center, Nashville, TN  Massachusetts General Hospital, Charlestown, MA  Massachusetts General Hospital/Harvard Medical School, Boston, MA  The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom  NHS, Liverpool, United Kingdom  Lyon University Hospital, Lyon, France  Institue of Neurology, UCL, London, United Kingdom  Johns Hopkins University, Baltimore, MD  Faculty of Medicine Siriraj Hospital, Bangkok Noi, Thailand  Vanderbilt University Medical Center, Nashville, TN  Khon Kaen University, Khon Kaen, Thailand  Mayo Clinic, Jacksonville, FL  John Radcliff Hospital Oxford Univeristy Hospitals Trust, Oxford, United Kingdom  Great Ormond Street Hospital, London, United Kingdom  Mayo Clinic Dept of Neurology, Rochester, MN